美的置業(03990.HK)與建設銀行簽署併購融資戰略合作協議
格隆匯3月22日丨美的置業(03990.HK)發佈公吿,公司與中國建設銀行廣東省分行已於2022年3月21日簽署《併購融資戰略合作協議》《支持發展保障性租賃住房戰略合作協議》和《按揭合作備忘錄》。
根據該等協議,建設銀行將分別授予集團人民幣100億元併購融資額度用於集團的併購業務;不低於人民幣20億元保障性租賃住房項目貸款支持總額以滿足相關租賃住房項目建設和日常運營等融資需求;及人民幣100億元住房按揭貸款專項額度用於集團地產開發項目的個人住房按揭貸款業務。
董事會認為,簽署該等協議有利於集團與建設銀行建立深度的戰略合作關係,為集團的相關業務開展提供充分的資金保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.